Phase I/II trial of GX 301 in patients with prostate cancer or renal cancer

Trial Profile

Phase I/II trial of GX 301 in patients with prostate cancer or renal cancer

Completed
Phase of Trial: Phase I/II

Latest Information Update: 04 Dec 2012

At a glance

  • Drugs GX 301 (Primary)
  • Indications Prostate cancer; Renal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Dec 2012 New trial record
    • 01 Feb 2012 Status changed from recruiting to completed.
    • 01 Oct 2011 The prostate cancer cohort of the trial was completed in October 2011. Recruitment was ongoing in the renal cancer cohort
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top